Accelerating the Fight
Against Head and Neck Cancer with Novel Diagnostic Technology
CANCER DIAGNOSTIC. EARLY MATTERS
Who We Are
Basin Genomics is a growing team of scientists, patient advocates, and entrepreneurs whose mission is to provide novel technology for the early detection of Head and Neck cancer. Founded in 2018, our goal is to increase the accessibility and efficacy of early oral cancer testing.
What We Do
We are laser-focused on commercializing diagnostic assays that identifies precancerous cellular changes enabling earlier cancer detection and allowing clinicians to provide a better standard of care resulting in improved health outcomes on a global scale.
Why We're Doing It
It’s simple. By finding cancer early, it will save lives– and reduce the physical, emotional, and financial effects of late-stage diagnosis in the process. We strongly believe early detection diagnostics is within reach. Connect with us to learn more.